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Managing chronic hepatitis B: A qualitative study
exploring the perspectives of people living with
chronic hepatitis B in Australia
Jack Wallace1*, Stephen McNally1, Jacqui Richmond2, Behzad Hajarizadeh1, Marian Pitts1
Abstract
Background: The implementation of a comprehensive public health response to hepatitis B in Australia is urgently
required to reduce the increasing burden of hepatitis B infection on the health system and the community. A
significant gap in the public health response to hepatitis B is an understanding of how people with chronic
hepatitis B (CHB) respond to CHB.
Findings: A qualitative study involving semi-structured interviews and focus group discussions was conducted.
Interviews were held with 20 people with CHB from three states of Australia. In addition, four focus group
discussions were held with a total of 40 community and health workers from culturally and linguistically diverse
communities in four Australian states.
People with CHB reported no formal or informal pre or post test discussion with little information about hepatitis B
provided at the point of diagnosis. Knowledge deficits about hepatitis B were found among most participants. Few
resources are available for people with CHB or their families to assist them in understanding the infection and
promoting their health and well-being. A lack of confidence in the professional knowledge of service providers was
noted throughout interviews.
Conclusions: People with CHB need culturally and linguistically appropriate education and information, particularly
at the point of diagnosis. Primary health care professionals need the knowledge, skills and motivation to provide
appropriate information to people with CHB, to ensure they have the capacity to better manage their infection.
Background
Hepatitis B is a blood-borne and sexually transmitted
viral infection. More than 2 billion people globally have
been exposed to hepatitis B with an estimated 350 mil-
lion people being chronically infected. Hepatitis B is the
cause of up to 1.2 million deaths per year worldwide [1].
Epidemiological studies estimate chronic hepatitis B
(CHB) prevalence in Australia to range between 0.5 and
2.1 percent [2-4] with the differences related to indirect
estimates and updated migration data. Most people with
chronic hepatitis B in Australia were born in highly
endemic countries in the Asia-Pacific region [3,5].
Despite improvements in clinical management, it has
been estimated that only a small proportion of people
with CHB, for whom treatment is recommended, receive
antiviral therapy [3,6]. This is resulting in an estimated
two to three fold increase in hepatitis B-related liver
cancer cases, with the numbers of people dying as a
result of CHB in Australia estimated to increase from
450 in 2008 to 1,550 in 2017 [7,8].
Previous health responses to hepatitis B in Australia
have relied on vaccination, securing the blood supply
and access to pharmaceutical treatments. This approach
is inadequate in responding to the increasing burden of
hepatitis B infection. The recent development of the
National Hepatitis B Strategy 2010-2013 [9] with its
goals of reducing the transmission, morbidity and mor-
tality caused by hepatitis B, and to minimise the perso-
nal and social impact of hepatitis B provides the
framework for implementing this response.
A significant gap in implementing this strategy is
identifying how people with CHB respond to their
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infection. This study aimed to record this information
by interviewing people with CHB and other stake-
holders. The reported findings are one component of an
extended qualitative research project aimed at develop-
ing a comprehensive public health response to hepatitis
B in Australia.
Methods
This qualitative study used interviews and focus group
discussions given the absence of non-statistical research
on people with CHB in Australia.
Face-to-face semi-structured interviews were carried
out with 20 people with CHB from Victoria, New South
Wales (NSW) and South Australia. Participants were
recruited through a public hospital liver clinic in Victoria;
non-government organisations including the Hepatitis C
Council of South Australia; Hepatitis NSW; the Hepatitis
Council of Queensland, and through the professional
networks of three investigators who had been involved in
national responses to other blood borne viruses.
Participants included 13 men and seven women with
ages ranging from late teens to mid 60 s. Six partici-
pants were born in Vietnam; five in China, three in
Cambodia and two from Afghanistan. Other participants
were from Australia, North America, Greece, and Tur-
key. The majority of participants had been diagnosed in
Australia within the previous 10 years with one person
diagnosed six weeks prior to the interview and two par-
ticipants diagnosed for 20 years. Purposive sampling
ensured variability in age, gender, ethnicity, state of resi-
dence, and exposure route.
One researcher conducted all interviews, guided by a
pilot tested interview schedule. The schedule sought
information on how people were diagnosed; their clini-
cal management experience, and their perspective on
the effect on their lives of having hepatitis B. All but
one interview was conducted in English with inter-
preters available if required.
Four focus group discussions were held in Victoria,
NSW, South Australia and Queensland with staff and
volunteers of non-government organisations providing
health and social support services to the communities
most at risk of CHB infection. Forty community or health
workers working with 12 different culturally and linguis-
tically diverse background (CALD) communities pro-
vided an understanding of the broader social context for
individuals with CHB, and of the impact of hepatitis B at
an individual, community and health service level. Focus
group participants were recruited through the Ethnic
Communities Council of Queensland, Multicultural HIV/
AIDS and Hepatitis C Service in NSW, the Hepatitis C
Council of South Australia and the Australian Research
Centre in Sex, Health and Society in Victoria. The focus
group discussion schedule, informed by the outcomes
from interviews with individuals, sought information
about community wide responses to hepatitis B; perspec-
tives of the needs of people with CHB, and how these
needs could be addressed; the importance of hepatitis B
within communities, and the priority of hepatitis B to the
communities most at risk. Focus group discussions took
between 60 and 90 minutes.
All interviews and focus groups were recorded, tran-
scribed, and verified. Data from the transcripts were
coded using Nvivo8 (QSR International Pty Ltd, VIC,
Australia). Analysis was conducted using grounded the-
ory by organising data into codes from which main
themes were identified as interviews progressed [10].
Two researchers independently analysed and discussed
results to reach consensus. Focus group and interview
data were compared, ensuring data and methodological
triangulation. Saturation was reached by the end of
interviews and focus group discussions.
The proposal was approved by the La Trobe Univer-
sity Human Research Ethics Committee and the South-
ern Health Human Research Ethics Committee
(Victoria).
Major themes
Major issues identified through the interviews and focus
group discussion included testing and diagnosing of
CHB; disclosure; clinical management, and participants’
beliefs and concerns about chronic hepatitis B infection.
All quotations are from people with CHB except where
otherwise indicated.
Testing and diagnosing infection
Hepatitis B testing occurred for participants in a range
of settings and within differing life contexts. These
included routine testing or as a consequence of employ-
ment screening; upon entry to drug rehabilitation, or as
one part of the immigration process. For several partici-
pants, testing for CHB occurred within a context of
entire families being tested:
My mother has hepatitis B ... and the family doctor
[suggested the family] have [a] hepatitis B blood test
... then we all found out we have hepatitis B ... the
whole family. (Chinese born woman, mid 30’s)
No participant reported receiving a formal or informal
pre- or post-test discussion and several did not remem-
ber providing consent for testing:
I didn’t ask for it, just through a normal blood test
(Vietnamese born man, late 30s)
Little information about hepatitis B or its impact was
provided to most of the participants at the point of
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diagnosis. One Chinese born man in his mid twenties
diagnosed four years prior to the interview reported:
They didn’t give me any information ... all I know is
that it was hepatitis B.
A major impact of the lack of pre - and post-test dis-
cussion and/or informed consent meant that receiving a
CHB diagnosis was described by several participants as
‘shocking.’ One participant who had been diagnosed in
Australia in 2007 noted:
The family doctor ... told me that I got it, it was shock-
ing, because I don’t really fully understand what
hepatitis B is but I know that sometimes it can lead to
serious problems. (Chinese born woman, early 20’s).
People’s limited information and understanding of
hepatitis B at the time of diagnosis created considerable
confusion and fear for their future. The following quotes
come from a Vietnamese born woman in her early 40 s
who had been diagnosed for 10 years, and a woman born
in China who had been diagnosed for 3 to 4 years:
I think it was like a cancer or something.
How long will I live? Will I survive? Will I be able to
have kids?
When relevant and accurate information is not pro-
vided at the point of diagnosis, some participants sought
information that reflected their cultural understandings
of health from within their communities and through
the internet. For one twenty year old man, born in
Afghanistan, and diagnosed in a refugee camp, the lack
of relevant information at the point of diagnosis
required further investigation:
I wasn’t sure what does it mean hepatitis B ... I asked
some other people and then they say this means this
kind of thing in our language we say ... it means that
this skin is yellow.
One health worker reported her experience in coun-
selling a person with CHB that reflected the essential
nature of pre/post-test discussion:
He was an intelligent, educated young man. But
because the GP hadn’t told him or started that slow
education counselling process, by the time he got to
me it was a huge catastrophe, he was going to die,
his wife was going to leave him... We need to situate
the disease in all the cultural issues.
Disclosure
There was diversity among the participants’ experi-
ences in disclosing their infection to family and the
broader community. The inter-generational nature of
hepatitis B transmission for one young woman meant
that there was no shame associated with infection,
and that disclosing her hepatitis B status was straight-
forward.
I had nothing to hide because it was given to me
from birth. (Australian born woman with Vietnamese
parents, mid 20s)
However, disclosure was not easy for all people that
we spoke with. Some respondents talked of complex
rules about disclosure for different friends and family
members in different situations. One man highlighted
that shrewdness was required to determine to whom
they would disclose their infection:
It’s about being almost street-smart. (American born
man, mid 40s)
One person had very clear rules about disclosure that
reduced the risk of negative responses to their infection:
If they don’t ask I’m not telling them. (Cambodian
born man, late 30s)
However, the fear of rejection or stigma at a personal
and community level was identified as an important
issue that restricted individual disclosure:
I didn’t let my brother know because he’s only 10 ... I
don’t want him to ... go to school and tell anyone
because kids are kids ... I don’t want to change his
life. (Chinese born woman, early 20s)
The impact of a CHB diagnosis and subsequent dis-
closure of this information within some communities
was reported by a health worker to lead to exclusion
from family and community life. Some community level
responses highlighted established ways of dealing with
vulnerability:
If you come from a different cultural background, the
way you avoid disease is through exclusion, and so if
that works with some things, then they [do the same
with hepatitis] (Community Worker)
People are really fearful, so when one partner is diag-
nosed with hepatitis B ... the other partner is wanting
to stay right away from them. (Community Worker)
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Some of the health professionals noted less stigma
related to hepatitis B particularly in comparison to other
sexually transmitted diseases:
It’s just called liver sickness ... hepatitis B is not seen
as a sexually transmitted disease, because ... you
don’t get the genital symptoms, it doesn’t have the
stigma as syphilis. (Health Worker)
Clinical Management
Perceptions of the availability, appropriateness and accu-
racy of information about hepatitis B for people with
CHB and health professionals were key themes in parti-
cipants’ beliefs about good management for CHB.
Several people noted that their deficits in information
had a significant effect on their behaviour which
resulted in poorer health outcomes:
I thought it was only a weak sign so I didn’t even
bother about [treatment] ... so I didn’t get regular
blood tests or anything. (Chinese born man, early
20s)
If they told me a few years ago that I wasn’t really
meant to drink alcohol ... I would have cut down on
it. (Cambodian born man, early 20s)
On the other hand, several participants reported effec-
tive health promoting responses such as reducing alco-
hol consumption:
After I found out I had hepatitis B, I quit drinking
after they told me drinking could make it really
worse for the liver .... It makes it better for life any-
way. (Chinese born man, mid 20s)
Three people including, one who had been diagnosed
in the past two years, noted that they weren’t being trea-
ted for hepatitis B because: not yet ...just a carrier. (Viet-
namese born man, late 20s)
In spite of Australia’s policy of vaccinating all newly
born children and providing vaccine and immunoglobu-
lin to neonates born to hepatitis B infected mothers,
missed opportunities for reducing transmission were
noted by one respondent whose child was infected with
hepatitis B at birth in Australia:
My daughter, she’s only two and a half ... we just
found out a year ago that she’s got hepatitis B, she
was born here. (Vietnamese born woman, mid 30s)
One participant, diagnosed six years previously, was
concerned that his GP was unable to respond effectively
to their need for information to help in self-monitoring:
I told the doctor that I had an e-antigen test, and he
goes ‘the result?’ and I go ‘I don’t know, it’s not
active’ or something and it was left there ... he hasn’t
followed [it] up. (Australian born man, late 20s)
One community worker noted the advice of their
agency to people with CHB had changed over time,
given the awareness of the agency in improvements in
hepatitis B clinical management. They were concerned
that GPs were not responding effectively to the needs of
people with CHB:
If you’ve been diagnosed with chronic hepatitis B, ask
your GP for a referral to a specialist ... I’ve noticed
that GPs will sit on hepatitis B in their own room for
years and years.
There were several instances when community and
health workers disclosed their lack of knowledge about
CHB:
Even the natural history - I’m not clear about it ... I
don’t even know if treatment is available (Commu-
nity Worker)
Knowledge, beliefs and concerns
Given the nature of CHB infection, several participants
reported other family members were infected and that
this affected family relationships. Sometimes these famil-
ial links, along with a lack of understanding of hepatitis
B, led to assumptions that challenged the view of hepati-
tis B as a virus:
The whole family have hep B except for my father ...
maybe it’s a blood thing. (Cambodian born man, late
30s).
Some people diagnosed with CHB in their country of
origin, reflected on the endemic nature of hepatitis B in
that country, and the lack of options available:
I got a test in Cambodia and the doctor told me I have
hep B, but in Cambodia it’s like normal, they don’t
care what happens. (Cambodian born man, late 30s)
Many participants associated hepatitis B with poor
sanitation, reflecting an inadequate understanding of
transmission risks:
I think I was infected in China, and we used to share
foods, drinks, so I think that’s how I got infected.
(Chinese born man, early 20s)
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A community worker working with people from
CALD backgrounds who inject drugs noted a perspec-
tive indicating a relationship between hepatitis and HIV,
with people progressing: from hepatitis A, to hepatitis B,
and hepatitis C then to HIV.
This incorrect understanding of viral hepatitis was also
noted by one man with CHB who understood hepatitis
as:
Three levels - hepatitis A, hepatitis B and hepatitis C
with hepatitis C being worse. (Afghani born man,
mid 50s)
Discussion
This study provides insight into the understandings and
responses to CHB infection by individuals with CHB.
The study found that most participants had not con-
sented to testing and received little or no information at
diagnosis; people with CHB had a poor understanding
of their infection, and had reservations in the capacity
of health professionals to respond effectively to CHB.
For most of our participants, testing for CHB infec-
tion occurred without the explicit informed consent of
the patient, and the CHB diagnosis occurred without
either written or verbal information being provided to
assist the patient understand the social implications or
clinical impact of the infection. National hepatitis C
and HIV testing policies have been developed in Aus-
tralia for health care workers including general practi-
tioners (GPs) that detail best practice in testing and
diagnosis, both of which are described as: ‘essential for
a patient to make an informed decision regarding ...
testing’ [11]. Both the HIV and hepatitis C testing poli-
cies specify pre-test and post-test discussion processes
including ensuring that the patient provides consent
for the test, that the patient is provided with informa-
tion about the social and clinical implications of diag-
nosis, including information about the condition being
tested for, clinical management options, and health
promotion information. While a testing protocol for
hepatitis B has been identified [5], its development and
implementation has not yet received national recogni-
tion or endorsement. Evidence based counselling
guidelines would provide a framework for ensuring
that people with hepatitis B understand the disease
and prognosis and are able to appropriately respond to
their infection [12].
The majority of people with CHB in Australia come
from CALD backgrounds, primarily from the Asia Paci-
fic region, and it has been previously reported that these
populations have inadequate levels of awareness and
knowledge about hepatitis B (13-15). The qualitative
methodology used in this study supported the findings
of these studies and provided a more nuanced perspec-
tive on the confusion about relationships between hepa-
titis viruses, and hepatitis viruses and HIV, treatment
and transmission risks.
Chronic hepatitis B is a complex condition mostly
affecting people who may have understandings of the
body that differ from those of the western medical
model. Providing information to people with CHB
describing the implications of infection requires a com-
prehensive understanding of the virus, and the skills to
be able to impart this information in a clear manner.
People with CHB expressed a lack of confidence in the
professional knowledge of service providers. General
practitioners and other primary health care professionals
need to be equipped with the information, expertise and
motivation to ensure that people with CHB understand
the natural history of the virus, the rationale for clinical
monitoring and the available treatments. The term ‘car-
rier’ with an assumed meaning of chronic hepatitis B
being inactive is not supported by current clinical man-
agement and yet was misunderstood by participants as
an encouraging sign. The lack of relevant information
provided to, or recalled by people with CHB about their
infection provided opportunities for people to seek
explanations of their infection that were culturally rele-
vant, although not necessarily accurate. Our findings
show that understandings of hepatitis B may be influ-
enced by cultural background, and that culturally and
linguistically appropriate interventions are required to
improve knowledge and assist in providing higher stan-
dards of care [16,17].
Australian public health responses to HIV and hepati-
tis C acknowledge the role of stigma and discrimination
as a result of transmission occurring through sex or
injecting drug use in the majority of infections [18,19].
Some participants in our study reported selective disclo-
sure of their infection to other people. Despite particular
cultural beliefs among some CALD communities about
illness or blood borne viruses, we found less evident
stigma related to hepatitis B than for hepatitis C and
HIV [20], particularly given the familial nature of infec-
tion for many of our participants. This is an area in
which further research is required.
Given sampling limitations, these findings have limited
generalisability; nonetheless, as the first qualitative study
exploring the perspective of people with CHB in Austra-
lia, this study provided information for the development
of a public health response to hepatitis B. In addition,
the qualitative data describing hepatitis B knowledge,
beliefs, and behaviours of people with CHB can be used
to develop population-based surveys. Such surveys could
quantify the knowledge and attitudes of people with
CHB and be used to develop culturally appropriate com-
munity-based interventions.
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English language proficiency was identified as the
main barrier in communicating between health care
providers about CHB in a study of Asian-Americans
[21]. This barrier was not directly addressed in our
study where most interviews were held in English and
participants had at least minimal English proficiency.
GPs were not specifically targeted for interview in this
study. Qualitative research describing GPs knowledge
and practice in response to CHB is a priority to identify
their perspective on barriers to effective CHB
management.
In conclusion, this study was the first in Australia and
one of the few internationally [12,22], to provide qualita-
tive data describing how people with CHB respond to
their infection. This information included identifying
significant gaps in culturally and linguistically appropri-
ate information and education, particularly at the point
of diagnosis. This provision of information will assist in
improving the knowledge and understanding of people
with CHB about their infection, and assist them in effec-
tively managing this infection. Primary health care pro-
fessionals, including GPs need the knowledge, resources,
expertise and skills to provide relevant and accurate
information to people with CHB. The role of stigma and
discrimination, a key topic in Australian national
responses to other blood borne viruses such as hepatitis
C and HIV, needs further investigation to determine the
extent and impact of these issues on people with CHB.
The study provided data that informed the development
of Australia’s first National Hepatitis B Strategy.
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